Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Quan Tang

Showing results (431-440 of 515) with videos related to

Pageof 52
Sort By:
European Journal of Radiology|September 20, 2025
Potential values of uEXPLORER total-body PET/CT in nasopharyngeal carcinoma: dynamic imaging and kinetic parametersYing-Ying Hu, Zhen-Chong Yang, Li-Ping Liang, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 22, 2023
Phase I dose-escalation study of nab-paclitaxel combined with cisplatin and capecitabin as induction chemotherapy followed by concurrent chemoradiotherapy in patients with nasopharyngeal carcinomaYu-Chen, Mei-Juan Luo, Rong-Ping Liu, et al.
Cancer Communications (London, England)|March 31, 2019
The diagnostic and prognostic values of plasma Epstein-Barr virus DNA for residual cervical lymphadenopathy in nasopharyngeal carcinoma patients: a retrospective studySai-Lan Liu, Xue-Song Sun, Xiao-Yun Li, et al.
Plos One|April 16, 2015
Elevated high-sensitivity C-reactive protein levels predict decreased survival for nasopharyngeal carcinoma patients in the intensity-modulated radiotherapy eraLin Quan Tang, Dong Peng Hu, Qiu Yan Chen, et al.
Oncotarget|December 31, 2015
Plasma Epstein-Barr viral DNA complements TNM classification of nasopharyngeal carcinoma in the era of intensity-modulated radiotherapyLu Zhang, Lin-Quan Tang, Qiu-Yan Chen, et al.
Oncotarget|March 17, 2016
Prognostic effect of pregnancy on young female patients with nasopharyngeal carcinoma: results from a matched cohort analysisLu Zhang, Huai Liu, Lin-Quan Tang, et al.
Therapeutic Advances in Medical Oncology|June 16, 2020
Induction chemotherapy followed by radiotherapy <i>versus</i> concurrent chemoradiotherapy in the treatment of different risk locoregionally advanced nasopharyngeal carcinomaLi-Ting Liu, Yu-Jing Liang, Shan-Shan Guo, et al.
Cancer Research and Treatment|March 28, 2019
Patterns of Failure and Survival Trends in 3,808 Patients with Stage II Nasopharyngeal Carcinoma Diagnosed from 1990 to 2012: A Large-Scale Retrospective Cohort StudyXue-Song Sun, Di-Han Liu, Sai-Lan Liu, et al.
Journal for Immunotherapy of Cancer|April 19, 2020
Development and validation of the immune signature to predict distant metastasis in patients with nasopharyngeal carcinomaSai-Lan Liu, Li-Juan Bian, Ze-Xian Liu, et al.
Oncogene|July 18, 2018
FMNL1 mediates nasopharyngeal carcinoma cell aggressiveness by epigenetically upregulating MTA1Wen-Hui Chen, Mu-Yan Cai, Jia-Xing Zhang, et al.
Pageof 52

Showing results (431-440 of 515) with videos related to

Sort By:
Pageof 52
European Journal of Radiology|September 20, 2025
Potential values of uEXPLORER total-body PET/CT in nasopharyngeal carcinoma: dynamic imaging and kinetic parametersYing-Ying Hu, Zhen-Chong Yang, Li-Ping Liang, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 22, 2023
Phase I dose-escalation study of nab-paclitaxel combined with cisplatin and capecitabin as induction chemotherapy followed by concurrent chemoradiotherapy in patients with nasopharyngeal carcinomaYu-Chen, Mei-Juan Luo, Rong-Ping Liu, et al.
Cancer Communications (London, England)|March 31, 2019
The diagnostic and prognostic values of plasma Epstein-Barr virus DNA for residual cervical lymphadenopathy in nasopharyngeal carcinoma patients: a retrospective studySai-Lan Liu, Xue-Song Sun, Xiao-Yun Li, et al.
Plos One|April 16, 2015
Elevated high-sensitivity C-reactive protein levels predict decreased survival for nasopharyngeal carcinoma patients in the intensity-modulated radiotherapy eraLin Quan Tang, Dong Peng Hu, Qiu Yan Chen, et al.
Oncotarget|December 31, 2015
Plasma Epstein-Barr viral DNA complements TNM classification of nasopharyngeal carcinoma in the era of intensity-modulated radiotherapyLu Zhang, Lin-Quan Tang, Qiu-Yan Chen, et al.
Oncotarget|March 17, 2016
Prognostic effect of pregnancy on young female patients with nasopharyngeal carcinoma: results from a matched cohort analysisLu Zhang, Huai Liu, Lin-Quan Tang, et al.
Therapeutic Advances in Medical Oncology|June 16, 2020
Induction chemotherapy followed by radiotherapy <i>versus</i> concurrent chemoradiotherapy in the treatment of different risk locoregionally advanced nasopharyngeal carcinomaLi-Ting Liu, Yu-Jing Liang, Shan-Shan Guo, et al.
Cancer Research and Treatment|March 28, 2019
Patterns of Failure and Survival Trends in 3,808 Patients with Stage II Nasopharyngeal Carcinoma Diagnosed from 1990 to 2012: A Large-Scale Retrospective Cohort StudyXue-Song Sun, Di-Han Liu, Sai-Lan Liu, et al.
Journal for Immunotherapy of Cancer|April 19, 2020
Development and validation of the immune signature to predict distant metastasis in patients with nasopharyngeal carcinomaSai-Lan Liu, Li-Juan Bian, Ze-Xian Liu, et al.
Oncogene|July 18, 2018
FMNL1 mediates nasopharyngeal carcinoma cell aggressiveness by epigenetically upregulating MTA1Wen-Hui Chen, Mu-Yan Cai, Jia-Xing Zhang, et al.
Pageof 52